… can be exploited for antifungal drug development. This has also resulted in a very restricted
number of antifungal drugs that are clinically available for the treatment of invasive fungal …

… In summary, the research articles and reviews presented in this Special Issue provide … insight
for the development of new antifungal drugs or intervention strategies. Identification of new, …

… In addition to studies that evaluate new antifungal agents as single agents, clinical trials
assess drug candidates as part of treatment along with the current standard of care. For example…

… It is important to add that resistance is a cross-cutting issue to all of the currently available
classes of antifungal agents, therefore overcoming antifungal resistance can be considered as …

… of new antifungal drugs, provides an overview of the most important molecules in terms of
basic (laboratory) research and compounds currently in clinical trials, and focuses on drug …

… the currently used drug classes. (1) The polyenes are the oldest antifungal drug class in
clinical use today and hallmarked a major clinical advancement in mycosis treatment. Although …

… Our review summarizes and compares the temporal development (eras) of antifungal drug
… New ideas and approaches were designed for bidirectional studies of the biochemistry of …

… drug targets, owing to their important roles in fungal viability and pathogenesis. In this review,
we discuss novel antifungal drugs … for investigating selective antifungal targets. Finally, we …

… for drug development purposes, the exploration of potential targets for novel antifungal
drug … In this review, we provide an overview of recent advancements in new antifungal drug …

… Currently, four antifungal drug classes are used by clinicians and veterinarians for systemic
… The research in antifungal drug development focuses on both old and new fungal targets. In …